As pharmaceutical research becomes even more complex, artificial intelligence methods are emerging as a useful tool in the field of biotechnology and drug research – with an increasing number of biotechnology companies and research centres now using cutting-edge AI techniques for a wide range of purposes.
As at 30 June 2016 – Frontier IP Group holding – 5%
Frontier IP Group plc (LON:FIPP), is an AIM listed UK based specialist asset management group whose focus and purpose is to provide consultancy services to assist universities and research organisations in the commercialisation of intellectual property arising from their research.